Average price of factor VIII by country 2017

This statistic displays the global average prices of Factor VIII in 2017 in selected countries. In that year, the price of factor VIII averaged 2.53 U.S. dollars in the United States. Factor VIII is a drug used, for example, to treat patients with hemophilia A.

Average prices of factor VIII in selected countries in 2017 (in U.S. dollars)*

Characteristic	Average price in U.S. dollars
United States	2.53
United Arab Emirates	1.09
United Kingdom	0.92
Switzerland	0.89
Germany	0.86
Netherlands	0.63
South Africa	0.27

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

December 2019

More information

Region

Worldwide

Survey time period

2017

Supplementary notes

* Prices for the United States were estimated by the Health Care Cost Institute using claims data on the commercially insured under age 65 who obtain health insurance through their employer.
Prices for Australia, Germany, Holland, New Zealand , South Africa, Switzerland, the UAE and the UK are are derived from unpublished local industry sources, collected and collated by the iFHP.
USA prescription drug prices are average point of sale price, which reflects discounts from the wholesale price, but not manufacturer rebates.
Drug prices for the UK were derived from the 2019 British National Formulary, which form the basis for both public and private drug prices.
All prices are based on 2017 data, converted at prevailing 2017 exchange rates to US dollars.

Citation formats